- Home
- CWBC vs KMDA Comparison
CWBC vs KMDA Comparison
Compare CWBC & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWBC
- KMDA
- Stock Information
- Founded
- CWBC 1989
- KMDA 1990
- Country
- CWBC United States
- KMDA Israel
- Employees
- CWBC N/A
- KMDA N/A
- Industry
- CWBC Major Banks
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- CWBC Finance
- KMDA Health Care
- Exchange
- CWBC Nasdaq
- KMDA Nasdaq
- Market Cap
- CWBC 395.8M
- KMDA 398.5M
- IPO Year
- CWBC 1996
- KMDA N/A
- Fundamental
- Price
- CWBC $21.54
- KMDA $7.05
- Analyst Decision
- CWBC Buy
- KMDA Strong Buy
- Analyst Count
- CWBC 3
- KMDA 2
- Target Price
- CWBC $21.67
- KMDA $13.00
- AVG Volume (30 Days)
- CWBC 74.1K
- KMDA 73.5K
- Earning Date
- CWBC 10-16-2025
- KMDA 11-10-2025
- Dividend Yield
- CWBC 2.24%
- KMDA 2.85%
- EPS Growth
- CWBC 309.48
- KMDA 30.41
- EPS
- CWBC 1.78
- KMDA 0.35
- Revenue
- CWBC $138,038,000.00
- KMDA $174,787,000.00
- Revenue This Year
- CWBC $31.79
- KMDA $14.49
- Revenue Next Year
- CWBC $9.42
- KMDA $10.12
- P/E Ratio
- CWBC $12.01
- KMDA $18.82
- Revenue Growth
- CWBC 45.29
- KMDA 10.36
- 52 Week Low
- CWBC $15.57
- KMDA $5.54
- 52 Week High
- CWBC $22.89
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- CWBC 56.77
- KMDA 54.66
- Support Level
- CWBC $21.29
- KMDA $6.55
- Resistance Level
- CWBC $21.65
- KMDA $6.93
- Average True Range (ATR)
- CWBC 0.48
- KMDA 0.18
- MACD
- CWBC 0.03
- KMDA 0.00
- Stochastic Oscillator
- CWBC 68.02
- KMDA 80.34
About CWBC Community West Bancshares
Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the Company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.